ARYx Therapeutics, Inc.
ARYX · OTC
12/31/2009 | 12/31/2008 | 12/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33,167 | -$31,218 | -$27,561 | -$27,328 |
| Dep. & Amort. | $1,080 | $1,463 | $1,238 | $920 |
| Deferred Tax | $425 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,931 | $0 | $0 | $0 |
| Change in WC | -$5,250 | -$17,744 | -$2,156 | $21,457 |
| Other Non-Cash | $439 | $2,281 | $774 | $738 |
| Operating Cash Flow | -$34,967 | -$45,218 | -$27,705 | -$4,213 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$141 | -$644 | -$499 | -$962 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$11,162 | -$16,706 | -$21,207 | -$69,385 |
| Inv. Sales/Matur. | $19,517 | $15,240 | $45,224 | $51,645 |
| Other Inv. Act. | $200 | -$300 | -$150 | $190 |
| Investing Cash Flow | $8,414 | -$2,410 | $23,368 | -$18,512 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,987 | $7,702 | -$2,896 | -$1,287 |
| Stock Issued | $1,042 | $20,449 | $44,049 | $30,217 |
| Stock Repurch. | -$92 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$2,037 | $28,151 | $41,153 | $28,930 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$28,590 | -$19,477 | $36,816 | $6,205 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35,999 | $55,476 | $18,660 | $12,455 |
| End Cash | $7,409 | $35,999 | $55,476 | $18,660 |
| Free Cash Flow | -$35,108 | -$45,862 | -$28,204 | -$5,175 |